
SHAWNEE MISSION, KAN. - 1/31/2007 - Bayer Healthcare LLC recently received Food and Drug Administration (FDA) approval for a new topical product targeting fleas, heartworms and intestinal nemotodes for both dogs and cats. Bayer officials report the approval and subsequent launch signal an important development for broad-spectrum parasite control. Advantage Multi-TM for Dogs Topical Solution and Advantage Multi-TM for Cats Topical Solution are available by prescription only through licensed veterinarians.



















